Fri, August 13, 2010
Thu, August 12, 2010
Wed, August 11, 2010
Tue, August 10, 2010
Mon, August 9, 2010
Fri, August 6, 2010
Thu, August 5, 2010
Wed, August 4, 2010
Tue, August 3, 2010
Mon, August 2, 2010
Fri, July 30, 2010
Thu, July 29, 2010
Wed, July 28, 2010
Tue, July 27, 2010
Mon, July 26, 2010

Spectranetics to Present at the Canaccord Genuity 30th Annual Global Growth Conference on August 10


//health-fitness.news-articles.net/content/2010/ .. nnual-global-growth-conference-on-august-10.html
Published in Health and Fitness on Tuesday, August 3rd 2010 at 11:06 GMT by Market Wire   Print publication without navigation


COLORADO SPRINGS, Colo.--([ BUSINESS WIRE ])--Spectranetics Corporation (Nasdaq:SPNC) today announced that it will present at the Canaccord Genuity 30th Annual Global Growth Conference to be held in Boston from August 10-12 at the Intercontinental Boston Hotel.

Guy A. Childs, Spectraneticsa™ chief financial officer, is scheduled to speak on Tuesday, August 10, 2010 at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) and will discuss the Company's growth drivers and market opportunities.

Interested parties can access a live audio webcast and slide presentation at [ www.spectranetics.com ]. An archived presentation will be available on the Web site for 14 days.

About Spectranetics

Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Companya™s products are sold in 40 countries throughout the world and are used to treat arterial blockages in the heart and legs as well as the removal of problematic pacemaker and defibrillator leads.

The Companya™s Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries above and below the knee and within coronary arteries. The Company also markets aspiration and thrombectomy catheters for the removal of thrombus and support catheters to facilitate crossing of coronary and peripheral arterial blockages.

The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of problematic pacemaker and defibrillator cardiac leads.

For more information, visit [ www.spectranetics.com ].


Publication Contributing Sources